Literature DB >> 11594862

Cantharidin revisited: a blistering defense of an ancient medicine.

L Moed1, T A Shwayder, M W Chang.   

Abstract

Cantharidin, a vesicant produced by beetles in the order Coleoptera, has a long history in both folk and traditional medicine. In dermatology, topical cantharidin has long been used to treat warts and molluscum. In 1962, cantharidin lost Food and Drug Administration (FDA) approval owing to the failure of its manufacturers to submit data attesting to cantharidin's efficacy. However, it is expected that the FDA will soon include cantharidin on its "Bulk Substances List," which would permit physicians or pharmacists to compound cantharidin to be used in the office for individual patients. A comprehensive discussion of the origins, folk uses, current FDA status, current dermatologic uses, and effects of cantharidin poisoning has been compiled herein. No cases of systemic intoxication or scarring have been reported with the proper use of cantharidin by a physician. Cantharidin is a safe and valuable medication and should be readded to the dermatologic therapeutic armamentarium.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11594862     DOI: 10.1001/archderm.137.10.1357

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  44 in total

1.  Leucoencephalopathy with brain stem and spinal cord involvement and lactate elevation: a novel mutation in the DARS2 gene.

Authors:  Anudeep Yelam; Elanagan Nagarajan; Miguel Chuquilin; Raghav Govindarajan
Journal:  BMJ Case Rep       Date:  2019-01-10

2.  Norcantharidin Inhibits SK-N-SH Neuroblastoma Cell Growth by Induction of Autophagy and Apoptosis.

Authors:  Zeping Han; Baoxia Li; Juanjuan Wang; Xiangqiang Zhang; Zhenhua Li; Liting Dai; Mingrong Cao; Jianwei Jiang
Journal:  Technol Cancer Res Treat       Date:  2016-07-08

3. 

Authors:  Kayley Ogilvie-Turner; Ran D Goldman
Journal:  Can Fam Physician       Date:  2020-06       Impact factor: 3.275

4.  Norcantharidin induces melanoma cell apoptosis through activation of TR3 dependent pathway.

Authors:  Shujing Liu; Hong Yu; Suresh M Kumar; James S Martin; Zhanyong Bing; Weiqi Sheng; Marcus Bosenberg; Xiaowei Xu
Journal:  Cancer Biol Ther       Date:  2011-12-01       Impact factor: 4.742

5.  Cantharidin for the treatment of molluscum contagiosum: a prospective, double-blinded, placebo-controlled trial.

Authors:  Jacquelyn Coloe Dosal; Paul W Stewart; Ja-An Lin; Christianna S Williams; Dean S Morrell
Journal:  Pediatr Dermatol       Date:  2012-08-16       Impact factor: 1.588

6.  Cantharidin Poisoning due to Blister Beetle Ingestion in Children: Two case reports and a review of clinical presentations.

Authors:  Ali M Al-Binali; Medhat Shabana; Suliman Al-Fifi; Sami Dawood; Amer A Shehri; Ahmed Al-Barki
Journal:  Sultan Qaboos Univ Med J       Date:  2010-07-19

7.  Cantharidin is Superior to Trichloroacetic Acid for the Treatment of Non-mucosal Genital Warts: A Pilot Randomized Controlled Trial.

Authors:  Maurice A Recanati; Katherine J Kramer; John J Maggio; Conrad R Chao
Journal:  Clin Exp Obstet Gynecol       Date:  2018       Impact factor: 0.146

Review 8.  Pediatric molluscum contagiosum: optimal treatment strategies.

Authors:  Nanette Silverberg
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

9.  Bioassay-guided isolation of cantharidin from blister beetles and its anticancer activity through inhibition of epidermal growth factor receptor-mediated STAT3 and Akt pathways.

Authors:  Jaemoo Chun; Min Kyoung Park; Hyejin Ko; Kyungjin Lee; Yeong Shik Kim
Journal:  J Nat Med       Date:  2018-07-24       Impact factor: 2.343

10.  Cantharidin for molluscum contagiosum.

Authors:  Kayley Ogilvie-Turner; Ran D Goldman
Journal:  Can Fam Physician       Date:  2020-06       Impact factor: 3.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.